Puma Biotechnology and Pierre Fabre’s Amendment of NERLYNX License Agreement

IN BRIEF: McDermott Will & Emery, advised on the matter.McDermott Will & Emery advised Pierre Fabre S.A. with a team including Anne-France Moreau (Life Science &…

This content is for Standard 1 Year members only.
Login Join Now
Naoual Sadouqi

Author: Naoual Sadouqi

This content is for Standard 1 Year members only.
Login Join Now